Zimmer Biomet Holdings Inc. (ZBH) saw its stock plummet 6.72% during Tuesday's intraday session.

The sharp decline follows the company's announcement that its Chief Financial Officer, Suketu Upadhyay, is departing effective immediately to pursue another professional opportunity. Controller and Chief Accounting Officer Paul Stellato has been named interim CFO while a permanent successor is sought.

This leadership transition has introduced uncertainty, overshadowing the company's positive first-quarter financial results. Zimmer Biomet reported adjusted earnings of $2.09 per share, beating analyst estimates, and raised its full-year adjusted earnings guidance. The market's negative reaction suggests investor concern over the sudden change in financial leadership outweighs the optimistic operational performance.